Funding - March 18, 2014
Karo Bio gets SEK 1 million from Vinnova
The company will be awarded 1 million SEK from Vinnova for the preclinical development of an ER-beta agonist for the treatment of multiple cancers. The grant will be awarded through Vinnova’s Forska & Väx program to finance toxicity and safety pharmacology studies of an ERbeta agonist. According to Karo Bio the compound has in previous […]
Collaboration - September 24, 2013
Karo Bio enters research collaboration
Karo Bio and 4D Science enters research collaboration on fibrotic diseases. The two companies will develop novel treatments for fibrotic diseases, based on a recent discoveries made by Dr. Jörg Distler. His research group has recently discovered that a specific nuclear receptor plays a key role in the pathogenesis of fibrotic diseases. The findings may […]
Collaboration - September 9, 2013
Karo Bio achieves milestone in Pfizer collaboration
The collaboration between Karo Bio and Pfizer has resulted in a significant achievement within the RORgamma project triggering the first milestone payment to Karo Bio. “The teams from Karo Bio and Pfizer have enjoyed an excellent interaction and relationship which has helped meet this goal. This achievement clearly demonstrates the value Karo Bio brings to […]
